Origo

Capital/Financing Update • Feb 2, 2022

National Storage Mechanism | Additional information

RNS Number : 3911A

Origo Partners PLC

02 February 2022

02 February 2022

Origo Partners Plc

("Origo" or the "Company")

Return of Capital and Asset Sale

Origo Partners Plc announces a return of capital of approximately USD 1.7 million to shareholders of record as at 18 February 2022 with payment to be made in US Dollars on or around 22 March 2022.   Pursuant to the Company's Articles of Association, eighty per cent of that amount will be distributed to the holders of the Company's redeemable preference shares at USD 0.02386 per redeemable preference share and twenty per cent of that amount will be distributed to the holders of the Company's ordinary shares at USD 0.00095 per ordinary share.

Following an auction process, Origo has entered into a contract to sell its entire interest in Moly World to Moly World's controlling shareholder for a cash consideration of USD 200,000.  The contract requires an initial payment of USD 100,000 which has now been received. The balance of USD 100,000 is due on completion which is on or before 31 March 2022.  Origo had invested USD 10 million in Moly World in 2011 and had carried the interest at nil. 

Ends

For further information about Origo please visit www.origopartners.com or contact: 

Origo Partners plc John Chapman Chairman	55 Athol Street Douglas Isle of Man IM1 1LA
Nominated Adviser and Broker Arden Partners plc Richard Johnson	+44 (0)20 7614 5900

The information contained within this announcement is deemed by the Company to constitute inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 ("MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCTBMBTMTMMTMT